rs142744204
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP2BP4_StrongBP6BS2
The NM_001378969.1(KCND3):āc.641A>Gā(p.Lys214Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000298 in 1,613,754 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001378969.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCND3 | NM_001378969.1 | c.641A>G | p.Lys214Arg | missense_variant | Exon 2 of 8 | ENST00000302127.5 | NP_001365898.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000329 AC: 50AN: 151948Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000196 AC: 49AN: 249806Hom.: 0 AF XY: 0.000221 AC XY: 30AN XY: 135444
GnomAD4 exome AF: 0.000295 AC: 431AN: 1461688Hom.: 1 Cov.: 31 AF XY: 0.000298 AC XY: 217AN XY: 727168
GnomAD4 genome AF: 0.000329 AC: 50AN: 152066Hom.: 1 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74318
ClinVar
Submissions by phenotype
not provided Benign:3
- -
- -
Reported in a patient with features of cerebellar ataxia referred for whole exome sequencing; however, this variant was inherited from an unaffected mother (Coutelier et al., 2018); Reported in one ostensibly healthy control individual and in association with atrial fibrillation (Giudicessi et al., 2011; Mann et al., 2012); Published functional studies demonstrate no damaging effect (Mann et al., 2012); This variant is associated with the following publications: (PMID: 26220970, 23838598, 25175087, 25410959, 29482223, 22402074, 21349352) -
Spinocerebellar ataxia type 19/22 Uncertain:1Benign:1
- -
- -
not specified Benign:2
- -
- -
KCND3-related disorder Uncertain:1
The KCND3 c.641A>G variant is predicted to result in the amino acid substitution p.Lys214Arg. This variant has been reported in individuals with episodic gait disorder, Brugada syndrome, or atrial fibrillation (Coutelier et al 2018. PubMed ID: 29482223; Di Resta C et al 2015. PubMed ID: 26220970; Mann SA et al 2012. PubMed ID: 22402074). However, this variant was also inherited from an unaffected parent of a proband with episodic gait disorder and was identified in controls for the Brugada syndrome study (Coutelier et al 2018. PubMed ID: 29482223; Di Resta C et al 2015. PubMed ID: 26220970; Giudicessi JR et al 2011. PubMed ID: 21349352). An in vitro study of this variant showed no change in cellular electrophysiology (Mann SA et al 2012. PubMed ID: 22402074). This variant is reported in 0.034% of alleles in individuals of European (Non-Finnish) descent in gnomAD, which may be too frequent to be a primary cause of autosomal dominant disease. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at